Literature DB >> 1613239

Genetic expression for type I procollagen in the early stages of flexor tendon healing.

R H Gelberman1, D Amiel, F Harwood.   

Abstract

To determine the precise mechanism by which contact tendon healing occurs at the cellular level, the production of pro alpha (I) collagen messenger RNA (mRNA) produced by fibroblasts of healing intrasynovial flexor tendons was determined by an in situ hybridization technique. The repair site and the proximal and distal tendon stumps of repaired tendons treated with early controlled passive mobilization were fixed and buffered in formalin, 3, 7, 10, and 17 days after repair. A complimentary DNA (cDNA) probe corresponding to alpha (I) procollagen mRNA was labeled with [32P]d-CTP. After hybridization, autoradiography, and staining of the sections, the level of procollagen mRNA was assessed by microscopic examination. Rising levels of procollagen mRNA, indicating progressively increasing levels of synthetic collagen activity, were detected in the healing tendons through 10 days. A moderate decrease in procollagen mRNA was seen at 17 days. Genetic expression for procollagen mRNA was localized specifically to the epitenon cells on the tendon surface overlying the repair site and to cells in the gap between the tendon stumps. No detectable expression was noted in endotenon fibroblasts. The finding of high levels of expression for procollagen type I mRNA in the surface layer of healing tendons demonstrates that cells intrinsic to tendon epitenon contribute the greatest quantity of native tendon collagen to the repair site during these important early intervals after tendon suture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613239     DOI: 10.1016/0363-5023(92)90370-5

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  7 in total

1.  The effects of exogenous basic fibroblast growth factor on intrasynovial flexor tendon healing in a canine model.

Authors:  Stavros Thomopoulos; H Mike Kim; Rosalina Das; Matthew J Silva; Shelly Sakiyama-Elbert; David Amiel; Richard H Gelberman
Journal:  J Bone Joint Surg Am       Date:  2010-10-06       Impact factor: 5.284

Review 2.  Toward guided tissue and bone regeneration: morphology, attachment, proliferation, and migration of cells cultured on collagen barrier membranes. A systematic review.

Authors:  Jan Behring; Rüdiger Junker; X Frank Walboomers; Betsy Chessnut; John A Jansen
Journal:  Odontology       Date:  2008-07-27       Impact factor: 2.634

3.  Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair.

Authors:  C N Manning; A G Schwartz; W Liu; J Xie; N Havlioglu; S E Sakiyama-Elbert; M J Silva; Y Xia; R H Gelberman; S Thomopoulos
Journal:  Acta Biomater       Date:  2013-02-13       Impact factor: 8.947

4.  Combined Administration of ASCs and BMP-12 Promotes an M2 Macrophage Phenotype and Enhances Tendon Healing.

Authors:  Richard H Gelberman; Stephen W Linderman; Rohith Jayaram; Anna D Dikina; Shelly Sakiyama-Elbert; Eben Alsberg; Stavros Thomopoulos; Hua Shen
Journal:  Clin Orthop Relat Res       Date:  2017-05-01       Impact factor: 4.176

5.  Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair.

Authors:  Shelly E Sakiyama-Elbert; Rosalina Das; Richard H Gelberman; Fredrick Harwood; David Amiel; Stavros Thomopoulos
Journal:  J Hand Surg Am       Date:  2008-11       Impact factor: 2.230

6.  Effect of adipose-derived stromal cells and BMP12 on intrasynovial tendon repair: A biomechanical, biochemical, and proteomics study.

Authors:  Richard H Gelberman; Hua Shen; Ioannis Kormpakis; Benjamin Rothrauff; Guang Yang; Rocky S Tuan; Younan Xia; Shelly Sakiyama-Elbert; Matthew J Silva; Stavros Thomopoulos
Journal:  J Orthop Res       Date:  2015-10-14       Impact factor: 3.494

7.  Differences between the cell populations from the peritenon and the tendon core with regard to their potential implication in tendon repair.

Authors:  Jennifer A Cadby; Evelyne Buehler; Charles Godbout; P René van Weeren; Jess G Snedeker
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.